American Academy of Ophthalmology
On Friday 11th October, London Medical’s very own retinal ophthalmology expert Philip Hykin presented a major research paper to over 3000 retina specialists at the annual meeting of the American Acadaemy of Ophthalmology in San Francisco.
The paper – ‘A Multicenter Phase 3 Double-Masked Randomized Controlled Noninferiority Trial Comparing the Clinical and Cost Effectiveness of Lucentis vs. Eylea vs. Avastin in Macula Edema Due to Central Retinal Vein Occlusion (LEAVO)’ – offers ophthalmologists greater insight into the cost-effectiveness and efficacy of some of the most popular anti-VEGF treatments for patients with macular edema due to central retinal vein occlusion.
Search treatments & services A-Z
Search for a specific treatment or service.
In other news
What is Wegovy and how does it work?
If you’ve been finding it difficult to lose weight despite your best...
What is Saxenda and how does it help with weight loss?
Managing your weight can feel discouraging, especially when your efforts don’t lead...
How does weight loss medication work?
In recent years, weight loss medications like Wegovy and Mounjaro have become...